209 filings
Page 8 of 11
8-K
hv55 g4x8
20 Apr 15
ChromaDex Appoints Former GlaxoSmithKline Executive, Jeff Baxter, to Its Board of Directors
12:00am
8-K
n7mmd8277 81hvk45
20 Mar 15
Departure of Directors or Certain Officers
12:00am
8-K
6lgax7rlmz1r51
3 Mar 15
ChromaDex® Appoints Former Nestlé Executive, Steve Allen, as Chairman
12:00am
8-K
rf24kay5 8nij337j2
11 Feb 15
Regulation FD Disclosure
12:00am
8-K
yqdwg1lybf8oer
12 Jan 15
Regulation FD Disclosure
12:00am
8-K
vw74l
3 Dec 14
ChromaDex® Receives $750,000 Cash from Previous Sale of its BluScience™ Line
12:00am
8-K
7kymdnnvwbi 05
2 Dec 14
ChromaDex Licenses Exclusive Worldwide Patent Rights from the University of Mississippi for Microalgae Technology Targeting Immune Support
12:00am
8-K
75c7txxm s035k
3 Oct 14
Entry into a Material Definitive Agreement
12:00am
8-K
x7uvf3qw ut7ld6tuy
30 Sep 14
ChromaDex Secures $5.0 Million in Growth Capital Financing from Hercules
12:00am
8-K
m59g2wo
22 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
fjdfvo
12 Aug 14
Regulation FD Disclosure
12:00am
8-K
ihinbh58y udbwmjt7tk
3 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
ht68 ifv0
10 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
6wxr 3wlhgl3lli
6 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
cy0jonor hqf9zo2
6 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
j654ufw31ixmjr7n at
3 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
4yjfsu1e
30 Dec 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
6a0x8
17 Dec 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
iqfqm
4 Dec 13
Regulation FD Disclosure
12:00am
8-K
6wiqopmc8t
21 Nov 13
Results of Operations and Financial Condition
12:00am